Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2118522
Abstract: ABSTRACT Introduction Elevated lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD). With the advent of the antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) targeted at LPA, that are highly effective… read more here.
Keywords: elevated levels; future directions; risk factor; pharmacotherapy children ... See more keywords